Home › Pain After Surgery › NCT06456268
VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)
Clinical Evaluation of an External Neuromodulation Device (VibraCool) to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Underwent ACL reconstruction Exclusion Criteria: * Pediatric iliotibial band ACL reconstruction (known to cause significantly more pain) * Non-english speakers (limitations of our study group)
About the study
The goal of this project is to test the effects of the VibraCool mechanical stimulation neuromodulatory therapeutic device on post-operative pain and opioid use following anterior crucitate ligament reconstruction (ACLR), and thus residual opioids in circulation.
What is being tested
- VibraCool mechanical stimulation and neuromodulatory therapeutic device (device)
- Cryocompression (Game Ready, Bregs) device (device)
- Standard ice packs (device)
Sponsor: Columbia University · Participants: 130 · Started: 2026-06
Contact the study team
Official record on ClinicalTrials.gov — NCT06456268
Locations in the U.S.
| New York | Columbia University Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.